RecruitingPhase 2Phase 3NCT06014138

Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome

Effect of Volatile Sedation on Spontaneous Breathing During Mechanical Ventilation for Patients With the Acute Respiratory Distress Syndrome


Sponsor

Guy's and St Thomas' NHS Foundation Trust

Enrollment

20 participants

Start Date

Nov 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study will investigate how different types of routine sedation may affect patient's breathing whilst on a ventilator in the Intensive Care Unit (ICU). There are different approaches to sedation which may have advantages and disadvantages. During the study patients will receive both intravenous and inhaled volatile sedation (similar to anaesthetic 'gases' used for general anaesthesia) and the drive to breath, breathing efforts and function of the lung will be assessed.


Eligibility

Min Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Isoflurane and a drug called Propofol for people with acute respiratory distress syndrome, mechanical ventilation complication, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 17 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPropofol

Standard care, propofol sedation - 2 hour periods of observation before and after inhaled volatile sedation

DRUGIsoflurane

Inhaled volatile sedation for 6 hours - 2 hours wash in / wash out, followed by 4 hours of observations


Locations(1)

Guy's & St Thomas' NHS Foundation Trust

London, London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06014138


Related Trials